Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.

dc.contributor.author

Rangel, ML

dc.contributor.author

Alghamdi, I

dc.contributor.author

Contreras, G

dc.contributor.author

Harrington, T

dc.contributor.author

Thomas, DB

dc.contributor.author

Barisoni, L

dc.contributor.author

Andrews, D

dc.contributor.author

Wolf, M

dc.contributor.author

Asif, A

dc.contributor.author

Nayer, A

dc.date.accessioned

2021-04-01T15:02:52Z

dc.date.available

2021-04-01T15:02:52Z

dc.date.issued

2013-07

dc.date.updated

2021-04-01T15:02:52Z

dc.description.abstract

Antiphospholipid syndrome (APS) is a distinct autoimmune prothrombotic disorder due to pathogenic autoantibodies directed against proteins that bind to phospholipids. APS is characterized by arterial and venous thrombosis and their clinical sequelae. Catastrophic antiphospholipid syndrome (CAPS) is a rare and often fatal form of APS characterized by disseminated intravascular thrombosis and ischemic injury resulting in multiorgan failure. Rarely, intravascular thrombosis in CAPS is accompanied by hemorrhagic manifestations such as diffuse alveolar hemorrhage. Here, we report a 43-year-old woman who presented with anemia, acute gastroenteritis, abnormal liver function tests, bilateral pulmonary infiltrates, and a systemic inflammatory response syndrome. The patient developed respiratory failure as a result of diffuse alveolar hemorrhage followed by acute renal failure. Laboratory tests disclosed hematuria, proteinuria, and reduced platelet count. Microbiologic tests were negative. A renal biopsy demonstrated acute thrombotic microangiopathy and extensive interstitial hemorrhage. Serologic tests disclosed antinuclear antibodies and reduced serum complement C4 concentration. Coagulation studies revealed the lupus anticoagulant and autoantibodies against cardiolipin, beta 2-glycoprotein I, and prothrombin. High-dose glucocorticoids and plasma exchange resulted in rapid resolution of pulmonary, renal, and hematological manifestations. This rare case emphasizes that CAPS can present with concurrent thrombotic and hemorrhagic manifestations. Rapid diagnosis and treatment may result in complete recovery.

dc.identifier

0961203313491024

dc.identifier.issn

0961-2033

dc.identifier.issn

1477-0962

dc.identifier.uri

https://hdl.handle.net/10161/22498

dc.language

eng

dc.publisher

SAGE Publications

dc.relation.ispartof

Lupus

dc.relation.isversionof

10.1177/0961203313491024

dc.subject

Pulmonary Alveoli

dc.subject

Humans

dc.subject

Respiratory Insufficiency

dc.subject

Thrombosis

dc.subject

Antiphospholipid Syndrome

dc.subject

Catastrophic Illness

dc.subject

Hemorrhage

dc.subject

Antibodies, Antinuclear

dc.subject

Glucocorticoids

dc.subject

Plasma Exchange

dc.subject

Dose-Response Relationship, Drug

dc.subject

Adult

dc.subject

Female

dc.title

Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.

dc.type

Journal article

duke.contributor.orcid

Barisoni, L|0000-0003-0848-9683

duke.contributor.orcid

Wolf, M|0000-0002-1127-1442

pubs.begin-page

855

pubs.end-page

864

pubs.issue

8

pubs.organisational-group

School of Medicine

pubs.organisational-group

Pathology

pubs.organisational-group

Medicine, Nephrology

pubs.organisational-group

Duke

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Basic Science Departments

pubs.publication-status

Published

pubs.volume

22

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2013Lupus_rangel_APAS_catastrophic.pdf
Size:
598.08 KB
Format:
Adobe Portable Document Format